Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Does nebulized heparin have value in acute respiratory distress syndrome patients in the setting of polytrauma

Egyptian Journal of Bronchology volume 11, pages 332–335 (2017)Cite this article

Abstract

Background

Several studies have been conducted with anticoagulants in the setting of experimental lung injury in animals and acute respiratory distress syndrome (ARDS) in humans. However, the clinical evidence for pulmonary anticoagulant therapy is still limited.

Aim

We aimed to assess the value of the use of nebulized heparin in ARDS patients in the setting of polytrauma.

Patients and methods

Eighty patients admitted with polytrauma and diagnosed to have ARDS and mechanically ventilated were enrolled. Patients were divided randomly into two groups, and each group included 40 patients: group 1 received nebulized heparin at a dose 5000 IU every 4 h, and group 2 served as control. All clinical and laboratory data were recorded. Patients were followed up during their whole ICU stay. All data were statistically analyzed.

Results

The mean age of the studied patients was 34.35± 14.6 and 34.87±14.86 years in group 1 and group 2, respectively. After 1 week, patients in group 1 had significant improvement in their PO2/FiO2 and lung injury severity score compared with patients in group 2 (231.1±42.7 and 1.82±0.66 vs. 203.6±45.9 and 2.35±0.35, P<0.001, respectively). Group 1 spent less days on mechanical ventilation and their length of ICU stay was lower compared with group 2 (9.6±13.5 and 12.7±4.3 days vs. 13.5±3.1 and 17.7±3.7 days, respectively, P<0.001). Other outcome parameters such as development of multiple organ dysfunction syndrome, the need to use vasoactive agents, and mortality did not differ between both groups (12, 62.5, and 20% vs. 15, 57.5, and 22.5%, P=0.5, 0.41, and 0.61, respectively).

Conclusion

Nebulized heparin may be beneficial and safe but has no survival benefit in ARDS patients in the setting of polytrauma.

References

  1. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161(Part 1):454–462.

  2. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31:S213–S220.

    Article  CAS  Google Scholar 

  3. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84:695–705.

    Article  CAS  Google Scholar 

  4. Vervloet MG, Thijs LG, Hack CE. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998; 24:33–44.

    Article  CAS  Google Scholar 

  5. Levi M, Schultz MJ, Rijneveld AW, Van Der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003; 31:S238–S242.

    Article  CAS  Google Scholar 

  6. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, et al. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 2004; 59:130–135.

    Article  CAS  Google Scholar 

  7. Hofstra JJ, Vlaar AP, Knape P, Mackie DP, Determann RM, Choi G, et al. Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J Trauma 2011; 70:1389–1397.

    Article  CAS  Google Scholar 

  8. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 16:L514–L521.

    Article  Google Scholar 

  9. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 16:1821–1828.

    Google Scholar 

  10. Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med 2003; 16:S243–S247.

    Article  Google Scholar 

  11. Suter PM. Nebulised heparin: a new approach to the treatment of acute lung injury? Crit Care 2008; 12:170.

  12. Dixon B, Santamaria JD, Campbell DJ. A phase 1 trial of nebulised heparin in acute lung injury. Crit Care 2008; 12:R64.

    Article  Google Scholar 

  13. Kroupa J. Definition of polytrauma and polytraumatism. Acta Chir Orthop Traumatol Cech 1990; 57:347–360.

    CAS  PubMed  Google Scholar 

  14. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307:2526–2533.

    Google Scholar 

  15. Kim M-S, Lee JS, Nam SB, Kang HJ, Kim JE. Randomized comparison of actual and ideal body weight for size selection of the laryngeal mask airway classic in overweight patients. J Korean Med Sci 2015; 30:1197–1202.

    Article  Google Scholar 

  16. Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care 2010; 14: R180.

    Article  Google Scholar 

  17. Holt J, Saffle JR, Morris SE, Cochran A. Use of inhaled heparin/N-acetylcystine in inhalation injury: does it help? J Burn Care Res 2008; 29:192–195.

    Article  Google Scholar 

  18. Kashefi NS, Nathan JI, Dissanaike S. Does a nebulized heparin/N-acetylcysteine protocol improve outcomes in adult smoke inhalation? Plast Reconstr Surg Glob Open 2014; 2:e165.

  19. Glas GJ, Neto AS, Horn J, Cochran A, Dixon B, Elamin EM, et al. Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis. Ann Intensive Care 2016; 6:33.

    Article  Google Scholar 

  20. Yip LY, Lim YF, Chan HN. Safety and potential anticoagulant effect of nebulised heparin in burns patients with inhalational injury at Singapore General hospital burns centre. Burns 2011; 37:1154–1160.

    Article  Google Scholar 

  21. Miller AC, Rivero A, Ziad S, Smith DJ, Elamin EM. Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res 2009; 30:249–256.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, Cairo University, Cairo, Kasr Alainy, 12111, Egypt

    Mohamed H. Saleh MD & Emad Omar

Authors
  1. Mohamed H. Saleh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emad Omar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamed H. Saleh MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saleh, M.H., Omar, E. Does nebulized heparin have value in acute respiratory distress syndrome patients in the setting of polytrauma. Egypt J Bronchol 11, 332–335 (2017). https://doi.org/10.4103/ejb.ejb_24_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_24_17

Keywords